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Abstract Earlier we detected a novel enzymatic activity in 
salivary gland secretion of the medicinal leech, splitting 
isopeptide bonds between the glutamine T-carboxamide and 
lysine E-amino group. This activity is due to destabilase. We 
described its partial amino acid sequence and sequences of two 
closely related cDNAs, but none of them perfectly matched the 
protein isolated. Here we report the isolation and sequence 
peculiarities of the third cDNA of the family as well as the 
complete sequence of the destabilase protein. The inferred 
mature protein product of this cDNA matches the independently 
determined destabilase protein sequence. It contains 115 amino 
acid residues including 14 highly conserved Cys residues and is 
formed from a precursor containing specific leader peptide. 
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1. Introduction 
Isopeptide bonds between side chains of Gin and Lys, e- 
( !-Glu)-Lys, are formed by specific transglutaminases and are 
important in vital processes uch as the final steps of blood 
coagulation [1-4]. The presence of transglutaminases in di- 
x erse organisms, organs, tissues and body fluids has long sug- 
gested that natural isopeptidases that antagonize the action of 
t'ansglutaminases might also exist. Recently we described 
sach an enzyme, an endo-E-(y-Glu)-Lys isopeptidase also 
tailed destabilase. The enzyme specifically splits isopeptide 
bonds in diisopeptides [5], between fibrin chains, but leaves 
t,olypeptide chains intact [6,7]. It dissolves tabilized fibrin in 
itro [8] and stimulates thrombolysis in experimental nimals 
['~]. Due to its ability to dissolve stabilized fibrin in vitro [8] 
~,nd thus to reverse the critical final step in blood coagulation 
[~)], destabilase is a potential thrombolytic agent. In our pre- 
x ious work [10] the corresponding protein was purified, its 
partial amino acid sequence determined, and two cDNAs en- 
t oding closely related but still different proteins were cloned 
and sequenced, emonstrating the existence of the gene family 
l ) r  destabilase related proteins. The structural homology cor- 
J elated with functional similarity of the destabilase and the 
t,roduct of one of the cDNAs cloned into a baculovirus ex- 
t,ression vector and expressed in insect cells. However, the 
polypeptides encoded by these two cDNAs were only partially 
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homologous to the independently isolated protein [10]. Here 
we describe the identification and sequence of a cDNA coding 
for the third member of the family with precisely the same 
sequence as the destabilase protein. We also report the se- 
quences of the peptides forming together the complete se- 
quence of the destabilase protein. 
2. Materials and methods 
2.1. General techniques 
The oligonucleotides used as adapters and/or PCR amplification 
primers are listed in Table 1. 
If not stated otherwise, standard procedures [11] were used. Total 
RNA was isolated from adult leeches using a guanidine isothiocyanate 
procedure [12]. The cDNA synthesis was carried out with a Marathon 
cDNA amplification kit (Clontech Laboratories, USA) according to 
the manufacturer's in tructions. 
The oligonucleotide duplex AP1/AP2 was ligated to the double 
stranded cDNA and the adapter ligated library was subsequently 
used for the PCR amplifications a  described below. 
2.2. PCR amplification ofthe destabilase cDNA fragments 
PCR amplification of the adapter ligated cDNA library was carried 
out with DsA and DsB primers corresponding to amino acid residues 
8-15 and 35-41 of the destabilase protein (Fig. 1B). The KlenTaq 
DNA polymerase (AB Peptides, USA) was used for amplification 
under the following conditions: 25 cycles, 94°C, 5 s; 50°C, 20 s; 
72°C, 30 s. PCR amplifications were done with 100 ng of single 
stranded cDNA and 50 pmol of each of the primers in 50 ml of the 
PCR mixture (10 mM Tris-HC1, pH 8.0, 50 mM KC1, 2.5 mM MgC12, 
0.01% gelatin, 200 M each dNTP, and 2.5 units of Taq DNA-poly- 
merase (Perkin Elmer-Cetus). Total leech cDNA was used for PCR 
amplification. 
Table 1 
Oligonucleotides used for the destabilase cDNA isolation and clon- 
ing 
Oligonucleotide Oligonucleotide s quence (5' ~ 3') 
designation 
AP 1 GTAATACGACTCACTATAGGGCTC- 
GAGCGGCCGCCCGGGCAGGT 
ACCTGCCCGGGC 
GAGCGGCCGCCCGGGCAGGT 
GTAATACGACTCACTATAGGGC 
CGTTGTATTTGYCARGTNGARGG 
GTATGGATCCTTWATYTGRTA 
ACTCAAGCTTCCAACATCCAT 
AGCGTCGACAGACTTCCTGCGTCCATG 
GCTCTAGAGATTGGAAGGTGCGGCA 
GCTCTAGAAGGTGGAAGGATGTAACAAT 
AP2 
AP3 
AP4 
DsA 
DsB 
P1 
P2 
P3 
P4 
Y = T+C, W = A+T+G, R = A+G, N = A+C+G+T. 
reserved. 
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The resulting product was cloned into a pBluescript SK vector 
(Stratagene, USA) linearized with BamHI and Sinai restriction endo- 
nucleases. 
2.3. Amplification of5'- and 3'-termini of the destabilase eDNA 
To obtain cDNA fragments covering the entire coding regions we 
used the Marathon RACE strategy originally reported earlier [13]. 
For all PCR reactions the hot start technique was applied with Taq- 
Start Antibodies (Clontech Laboratories), according to the instruc- 
tions of the manufacturer. 
The 5'-RACE procedure was implemented with an adapter ligated 
cDNA library with the nested PCR primer pairs AP1 and P1 for the 
first round and AP2 and P2 for the second round. The first round 
included 25 cycles under the following conditions: 95°C, 3 s; 60°C, 
20 s; 72°C, 1 rain. 
The reaction mixture was 10-fold iluted and used for 20 cycles of 
amplification i the second round of PCR under the same conditions. 
The 3'-RACE procedure was performed as described above with 
AP1 and P3 primers for the first round and AP2 and P4 pair for the 
second round. 
The resulting products were cloned into a pBluescript SK vector 
linearized with XbaIlSalI and XmaIIIISalI restriction endonucleases 
[14]. 
2.4. DNA sequencing 
The plasmids were sequenced by the termination method using 
Sequenase Version 2.0 DNA polymerase (US Biochemicals) [15]. 
Both strands of the cDNA were sequenced. At least hree independent 
clones for each PCR product were sequenced to determine the final 
sequence. 
2.5. Protein primary structure determination 
Isolation and purification of the destabilase protein, sequencing of
its 36 N-terminal amino acids, and isolation and sequencing of four 
BrCN peptides (14, Fig. 1) have been described earlier [10]. To com- 
plete sequencing the longest BrCN peptide, 2(Fig. 1B), started in [10], 
it was digested with Staphylococcus aureus glutamic acid specific pro- 
tease V-8 ('Sigma') by the method escribed in[15]. Vertical arrows in 
Fig. 1B indicate positions of the splits. The shorter peptides were 
sequenced asdescribed [10]. The sequence of 10 C-terminal amino 
acids of BrCN peptide 4 (Fig. 1B) was also determined asdescribed 
in [10]. 
3. Results and discussion 
3.1. The complete primary structure of the destabilase protein 
Earlier we presented a partial amino acid sequence of the 
destabilase protein. The destabilase protein was split into four 
fragments with BrCN. Two of the fragments have been se- 
quenced previously [10], but the longest one, 2, as well as C- 
terminal peptide 4 (Fig. 1B) remained unfinished. Now we 
have completed the sequencing of the peptides covering all 
115 amino acids of the protein sequence. For this goal frag- 
ment 2 was digested with a glutamic acid specific protease, the 
resulting shorter fragments equenced, and the whole struc- 
ture of the fragment thus determined. The primary structures 
of the peptides equenced are shown in Fig. 1B. Several ques- 
tions still remain to be answered, all pertinent to posttransla- 
tional modifications of the protein. Our preliminary data 
based on mass spectrometry of the peptides implied that 
some covalently bound groups were associated with the pro- 
tein. In particular, there is rather strong evidence that one of 
such groups is attached to the heptapeptide containing Thr 64 
(our unpublished ata). The involvement of 14 cysteines of 
the protein polypeptide chain in disulfide bridge formation 
should also be investigated. The corresponding experiments 
are now in progress. 
3.2. Cloning and analysis of the third type of destabilase related 
cDNAs (Ds3) 
In our recent work [10] we were able to clone two closely 
related cDNAs, Dsl and Ds2, encoding two homologous but 
not identical proteins which were in turn partially homolo- 
gous to the destabilase protein. Therefore we came to the 
conclusion that there exists a destabilase gene family of at 
least three members corresponding to three different proteins. 
However, we failed to isolate the cDNA precisely encoding 
the identified protein. In search for the missing cDNA we 
prepared a new cDNA library ligated to adapter API/AP2 
and used it for PCR amplification with two degenerate prim- 
ers corresponding to positions 8-15 (RCICQVEG, primer 
DsA) and 35-41 (YQIKEPY, primer DsB) of the destabilase 
mature protein (Fig. 1B). Twenty-four individual clones con- 
taining amplified 115 bp long fragments were isolated and 
sequenced. Eighteen of them contained a characteristic se- 
quence ncoding the NNE tripeptide distinguishing the desta- 
bilase protein from the amino acid sequences inferred from 
Dsl and Ds2 cDNAs [10]. The sequence obtained was used 
for specific PCR amplifications of the corresponding 5'- and 
3'-termini of the mRNA according to the Marathon cDNA 
amplification procedure [13]. Finally, the whole coding se- 
quence matching the sequence of the destabilase protein was 
obtained (Fig. 1A). The open reading frame was 135 amino 
acids long followed by UGA stop codons and a polyadenyla- 
tion signal AAUAAA. 
Table 2 shows the identity between the primary structures 
of the three destabilase mRNAs and proteins. 
Ds3 mRNA in its coding part was most similar to Dsl 
mRNA and markedly different from Ds2. This suggests that 
Dsl and Ds3 genes had a common ancestor that had diverged 
from the Ds2 gene earlier in the evolution. The remarkable 
identity in the 5'-noncoding regions of Dsl and Ds3 mRNAs 
as opposed to the totally different 5'-noncoding sequence of 
the Ds2 mRNA is in line with the hypothesis. The Y-noncod- 
ing regions of all three mRNAs were completely different. All 
the mRNA contexts urrounding initiation AUG codons did 
not completely match the consensus GCCA/GCCAUGG [20] 
but had A residues at an important position +4. The G+C 
content of Ds3 mRNA in coding region is 51.0, as compared 
to 50.0 and 44.5 for Dsl and Ds2 mRNAs, respectively. In all 
cases the G+C levels of the noncoding parts were lower as 
compared to the coding regions, in accord with the general 
rules of the G+C content distribution [16]. 
Table 2 
Identity between mRNAs and protein primary structures for the three destabilase forms 
Percentage of identity between: 
Forms under comparison mRNAs (coding parts) Protein precursors Mature proteins 
Dsl-Ds2 62.5 60.0 66.1 
Dsl-Ds3 88.2 79.3 75.7 
Ds2-Ds3 64.0 62.2 68.7 
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A DS3 GAACT GCAATCTTAATATCTCACTA AT~G AAT TAC GTT ATC TTT GTG GTC TTA GTG GCA CTT 62 
Dsl CTTGAGCT . . . . . .  A . . . . . . . . . . . . . . . . . .  G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  70 
DS2 AGTA-TGAAAATTCACCTT-CGGA- -AGG . . . .  TC ATT  -CA - -T  -A- - -T TC- C--  -CT CTT - -A  65 
DS3 TAC GTC ATC C~ GTA GCG AAG TGC . . . .  122 
Dsl . . . . . . . . . . . . . . . . . . . . . . . .  130 
DS2 AT-  -C- TCT -T- -AG -T- - -T A--.. . . . . .  - . . . . .  " 125 
Ds3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  182 
Dsl 190 
Ds2 185 
Ds3 " " 242 
Dsl 250 
Ds2 245 
Ds3 302 
Dsl 310 
Ds2 i~-- +i 305 
Ds3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  + . . . . . . . . .  ~ ............ r 'i 362 
DSl : ~ !  370 
Ds2 365 
DS3 . . . . . .  419 
Dsl 427 
Ds2 425 
Ds3 ~ TGA .CATTGCC TCAAGGTCGGCCAT T T TAAAGATGGC TGC TGTTG 493 
Dsl ~ -C - -GAC-TT-TCGT- -G-T -CAGTCTGCCA. . .  T -TT -AAAG-T-GXX- - -CTCAAAT 498 
Ds2 -T . . . . . . . . .  TCG-A-  TCT- - -AG-AGCXCC T- T - TTA~A-  TTGA-A-  - -CTT-  TAAT 490 
Ds3 ATGTATCAAATTCTAAATTAAAC4MtAAGXCATTTTTAAATTGAATAAATACCAAATGATAAATG 559 
Dsl TCTA-ATTGTAAAG-G- - -TCTAC-G-CAG-A- -A -T -G  . . . . . .  TTT- -AT  . . . .  T - - -TTAAAATTGT 569 
Ds2 TCAA-ATT-T - -TGGG-A-C  . . . . . . . . .  X -A -GA-TTTAAAC- -TT- -TTG . . . .  T - -TCXGAAATAGAAACAACTAT 560 
DS2 AAAT TGC TCCAAGAAT TGTATAATCATGAAGTGT T TGAAAC43 TGT T T TC TGAAATAAAC T TCCCATAAAT 630 
B 
prot .  
Ds3 
Ds l  
Ds2  
U_~_ 1 ~ ~ 2 
• " "  • " ' I "  " ,I, 
. . . . . . . . . . . . . . . . . . . . . . . . . . .  . . . .  D . . . . . . . . . . . . . . .  a0 
~ o P ' 1 - o  s . . . . . .  I<-~--Dso~-K . . . .  v . . . . . . . . . . .  x -  60 
LIA 
• . T .  
prot .  YWIDCGRPGGGIQQCTKF2KAC SER _~_  _ .Y~RYARRCTGGRQPTCQDYAKIHN~~ 10 0 
Ds3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  120 
Ds l  . . . . . .  S - -A - J -E  . . . . . . . . . .  H -XX . . . . .  X . . . .  R -XX . . . . . . . . . . . . .  ~- - -~ 120 
I I I I Ds2 . . . . . .  K . . . .  JES - - -N  . . . . . .  " J -R - - -K - -G-F  . . . . .  T . . . . . . .  R - - -G- "~R- - I~  120 
prot .  
Ds3 . . . . .  
Ds l  IRTS-~ 
Ds2  I - -AT~ 
_ _  4 
• 115 
135 
- -NKANA- -N  135  
I - -NK-QK- -R  136  
:ig. 1. Alignments of cDNA nucleotide and inferred amino acid sequences of Dsl ,  Ds2 and Ds3, and destabilase protein. A: Alignment of 
:)sl, Ds2 and Ds3 cDNA nucleotide sequences (EMBL accession umbers U24121 and U24122 for Dsl  and Ds2. Ds3 is being prepared for 
+ubmission). Hyphens indicate identical nucleotides. Initiation and stop codons as well as putative polyadenylation signals are underlined. Cod- 
mg sequences of  the mature proteins are shown in the shaded box. B: Alignment of the amino acid sequences deduced from Dsl,  Ds2, and 
Ds3 cDNAs and the amino acid sequence of destabilase protein (prot.). Hyphens indicate identity with the corresponding residues in the Ds3 
sequence in the signal part (underlined) and with the destabilase protein in mature protein regions. Regions enriched in hydrophilic residues are 
boxed. The positions of 14 conserved cysteine residues are marked with black circles. The peptides resulting from BrCN splitting of the destabi- 
iase protein are numbered above the protein amino acid sequence. Vertical arrows indicate the positions of the longest BrCN peptide digestion 
with Staphylococcus protease V-8. 
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3.3. The destabilase protein, its precursor and comparison with 
other members of the protein family 
The comparison of the deduced amino acid sequence with 
the N-terminal structure of the protein allows one to conclude 
that the destabilase is translated as a precursor containing a
20 amino acids long potential signal peptide (Fig. 1B). Signal 
peptides of this kind are cleaved from the precursor by signal 
peptidases [17,18]. This finding correlates with destabilase se- 
cretion and is a common feature of all three members of the 
family. Although the sequences of the three signal peptides 
were not identical, all of them retained major characteristics 
of the leader part of the protein precursors transported to the 
endoplasmic reticulum: they were enriched in apolar amino 
acids and separated from the mature protein by polar amino 
acid residues. 
The mature destabilase Ds3 protein consists of 115 amino 
acid residues. It shares 75.7 and 66.1% identity with Dsl and 
Ds2 polypeptides, respectively. Like the two other proteins it 
is characterized by a high cysteine content (14 of the 115 
amino acid residues, in contrast to an average cysteine content 
of about 3%). The positions of Cys residues were conserved in 
all three amino acid sequences, which suggests their functional 
and structural importance. Three very hydrophilic regions 
were present in the protein at positions 14-20, 53-65, and 
97-105 of the mature polypeptide. The regions are very con- 
servative among the three proteins and might be directly in- 
volved in the isopeptidase mechanism. 
Only one difference was detected between the inferred pro- 
tein sequence and that obtained by direct peptide sequencing: 
at position 64 of the mature protein (Fig. 1B) the deduced 
protein chain contains an Arg residue in contrast o a Thr 
residue in the isolated protein. At present we do not know the 
reason for this discrepancy. Several cDNA clones sequenced 
independently gave the same Arg residue at this point. Possi- 
bly, the sequence of the peptide has to be reconfirmed at this 
position because according to the mass spectrometry data 
Thr 64 can be modified by a group attached to it. Such a 
modification could lead to erroneous residue determination. 
The substitution Arg--* Thr can also be caused by just one 
point mutation AGG (Arg)~ACG (Thr). It should be men- 
tioned that two other cDNAs encode Thr at this position. 
As well as mRNA data, differences in the three protein 
structures (the distribution of hydrophobic and hydrophilic 
regions, overall content of basic and acidic amino acids, 
etc.) are also in favor of early evolutionary divergence of 
members of the destabilase gene family, and possibly suggest 
some functional differences between the enzymes as to sub- 
strate specificity or kinetic behavior. 
No clear-cut homology to destabilase was found in public 
databases [19]. Some short polypeptide stretches homologous 
to segments of different proteins were discussed previously. In 
view of PMSF inhibition of destabilase activity (our unpub- 
lished data), a serine residue might be a part of the active 
center. Short motifs loosely homologous to the known con- 
sensus GDSGGP [20] of some serine proteinases were found 
at positions 4-8 (DSCLR), 15-21 (GCDSQIG) and 26-34 
(DVGSLSCGP). All three proteins contain the only histidine 
residue (His 92) that might be involved in the active center 
function. The destabilase could be reasonably suggested to 
share homology with transglutaminases. But no math was 
found, even with the consensus equence of transglutaminase 
active centers (YGQCWVFA [4]). 
Homologies were seen between residues 31-62 of Ds2 and 
residues 243-274 of the thrombospondin related anonymous 
protein (TRAP) [21] and between residues 2-15 of Dsl and 
positions 4-17 of a novel lysozyme from Asterias rubens [22], 
although the meaning of these homologies is unclear. 
The discovery of the gene family and proteins with appar- 
ently similar functional ability to digest isopeptide bonds 
brings up many questions on their role in the life of the leech. 
In this connection it would be necessary to study kinetic and 
regulatory properties of the different forms, tissue specificity 
of their expression, their balance in the course of develop- 
ment, and, most importantly, whether digestion of isopeptide 
bonds is the only function of these enzymes. If similar en- 
zymes and genes exist also in other organisms remains to be 
answered as well. 
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